ID   ISPH_ECOLI              Reviewed;         316 AA.
AC   P62623; P22565;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   15-MAR-2017, entry version 109.
DE   RecName: Full=4-hydroxy-3-methylbut-2-enyl diphosphate reductase;
DE            EC=1.17.7.4 {ECO:0000269|PubMed:12198182, ECO:0000269|PubMed:12571359};
GN   Name=ispH; Synonyms=lytB, yaaE; OrderedLocusNames=b0029, JW0027;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHARACTERIZATION.
RX   PubMed=11818558; DOI=10.1073/pnas.032658999;
RA   Rohdich F., Hecht S., Gaertner K., Adam P., Krieger C., Amslinger S.,
RA   Arigoni D., Bacher A., Eisenreich W.;
RT   "Studies on the nonmevalonate terpene biosynthetic pathway: metabolic
RT   role of IspH (LytB) protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:1158-1163(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=2011499; DOI=10.1093/nar/19.1.180;
RA   Bouvier J., Stragier P.;
RT   "Nucleotide sequence of the lsp-dapB interval in Escherichia coli.";
RL   Nucleic Acids Res. 19:180-180(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=1630901; DOI=10.1093/nar/20.13.3305;
RA   Yura T., Mori H., Nagai H., Nagata T., Ishihama A., Fujita N.,
RA   Isono K., Mizobuchi K., Nakata A.;
RT   "Systematic sequencing of the Escherichia coli genome: analysis of the
RT   0-2.4 min region.";
RL   Nucleic Acids Res. 20:3305-3308(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [6]
RP   IDENTIFICATION.
RX   PubMed=8432714; DOI=10.1128/jb.175.4.1203-1205.1993;
RA   Gustafson C.E., Kaul S., Ishiguro E.E.;
RT   "Identification of the Escherichia coli lytB gene, which is involved
RT   in penicillin tolerance and control of the stringent response.";
RL   J. Bacteriol. 175:1203-1205(1993).
RN   [7]
RP   PATHWAY.
RC   STRAIN=K12 / ATCC 23716 / DSM 498;
RX   PubMed=11418107; DOI=10.1016/S0014-5793(01)02516-9;
RA   Altincicek B., Kollas A.-K., Eberl M., Wiesner J., Sanderbrand S.,
RA   Hintz M., Beck E., Jomaa H.;
RT   "LytB, a novel gene of the 2-C-methyl-D-erythritol 4-phosphate pathway
RT   of isoprenoid biosynthesis in Escherichia coli.";
RL   FEBS Lett. 499:37-40(2001).
RN   [8]
RP   PATHWAY.
RX   PubMed=11717301; DOI=10.1128/JB.183.24.7403-7407.2001;
RA   McAteer S., Coulson A., McLennan N., Masters M.;
RT   "The lytB gene of Escherichia coli is essential and specifies a
RT   product needed for isoprenoid biosynthesis.";
RL   J. Bacteriol. 183:7403-7407(2001).
RN   [9]
RP   CATALYTIC ACTIVITY.
RX   PubMed=12198182; DOI=10.1073/pnas.182412599;
RA   Adam P., Hecht S., Eisenreich W., Kaiser J., Graewert T., Arigoni D.,
RA   Bacher A., Rohdich F.;
RT   "Biosynthesis of terpenes: studies on 1-hydroxy-2-methyl-2-(E)-butenyl
RT   4-diphosphate reductase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:12108-12113(2002).
RN   [10]
RP   IRON-SULFUR CLUSTER, AND SUBUNIT.
RX   PubMed=12706830; DOI=10.1016/S0014-5793(03)00317-X;
RA   Wolff M., Seemann M., Tse Sum Bui B., Frapart Y., Tritsch D.,
RA   Garcia Estrabot A., Rodriguez-Concepcion M., Boronat A., Marquet A.,
RA   Rohmer M.;
RT   "Isoprenoid biosynthesis via the methylerythritol phosphate pathway:
RT   the (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase (LytB/IspH)
RT   from Escherichia coli is a [4Fe-4S] protein.";
RL   FEBS Lett. 541:115-120(2003).
RN   [11]
RP   CATALYTIC ACTIVITY.
RX   PubMed=12571359; DOI=10.1073/pnas.0337742100;
RA   Rohdich F., Zepeck F., Adam P., Hecht S., Kaiser J., Laupitz R.,
RA   Graewert T., Amslinger S., Eisenreich W., Bacher A., Arigoni D.;
RT   "The deoxyxylulose phosphate pathway of isoprenoid biosynthesis:
RT   studies on the mechanisms of the reactions catalyzed by IspG and IspH
RT   protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:1586-1591(2003).
RN   [12]
RP   PRESENCE OF A 3FE-4S IRON-SULFUR CLUSTER, ENZYME REGULATION, KINETIC
RP   PARAMETERS, AND MUTAGENESIS OF CYS-12; CYS-96 AND CYS-197.
RX   PubMed=15469281; DOI=10.1021/ja0471727;
RA   Graewert T., Kaiser J., Zepeck F., Laupitz R., Hecht S., Amslinger S.,
RA   Schramek N., Schleicher E., Weber S., Haslbeck M., Buchner J.,
RA   Rieder C., Arigoni D., Bacher A., Eisenreich W., Rohdich F.;
RT   "IspH protein of Escherichia coli: studies on iron-sulfur cluster
RT   implementation and catalysis.";
RL   J. Am. Chem. Soc. 126:12847-12855(2004).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH IRON-SULFUR
RP   (3FE-4S), FUNCTION, COFACTOR, SUBUNIT, AND MUTAGENESIS OF HIS-41;
RP   HIS-74; VAL-99; HIS-124; GLU-126; THR-167; SER-225 AND ASN-227.
RX   PubMed=19569147; DOI=10.1002/anie.200900548;
RA   Graewert T., Rohdich F., Span I., Bacher A., Eisenreich W.,
RA   Eppinger J., Groll M.;
RT   "Structure of active IspH enzyme from Escherichia coli provides
RT   mechanistic insights into substrate reduction.";
RL   Angew. Chem. Int. Ed. Engl. 48:5756-5759(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH SUBSTRATE AND
RP   IRON-SULFUR (3FE-4S), FUNCTION, COFACTOR, SUBUNIT, AND MUTAGENESIS OF
RP   CYS-12; CYS-96 AND CYS-197.
RX   PubMed=20080550; DOI=10.1073/pnas.0913045107;
RA   Graewert T., Span I., Eisenreich W., Rohdich F., Eppinger J.,
RA   Bacher A., Groll M.;
RT   "Probing the reaction mechanism of IspH protein by x-ray structure
RT   analysis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:1077-1081(2010).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) IN COMPLEX WITH SUBSTRATE AND
RP   IRON-SULFUR (4FE-4S), FUNCTION, COFACTOR, SUBUNIT, AND MUTAGENESIS OF
RP   GLU-126 AND THR-167.
RX   PubMed=22137895; DOI=10.1016/j.jmb.2011.11.033;
RA   Span I., Graewert T., Bacher A., Eisenreich W., Groll M.;
RT   "Crystal structures of mutant IspH proteins reveal a rotation of the
RT   substrate's hydroxymethyl group during catalysis.";
RL   J. Mol. Biol. 416:1-9(2012).
CC   -!- FUNCTION: Converts 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate
CC       into isopentenyl diphosphate (IPP) and dimethylallyl diphosphate
CC       (DMAPP). Is also involved in penicillin tolerance and control of
CC       the stringent response. Seems to directly or indirectly interact
CC       with RelA to maintain it in an inactive form during normal growth.
CC       {ECO:0000269|PubMed:19569147, ECO:0000269|PubMed:20080550,
CC       ECO:0000269|PubMed:22137895}.
CC   -!- CATALYTIC ACTIVITY: Isopentenyl diphosphate + 2 oxidized
CC       ferredoxin [iron-sulfur] cluster + H(2)O = (E)-4-hydroxy-3-
CC       methylbut-2-en-1-yl diphosphate + 2 reduced ferredoxin [iron-
CC       sulfur] cluster + 2 H(+). {ECO:0000269|PubMed:12198182,
CC       ECO:0000269|PubMed:12571359}.
CC   -!- CATALYTIC ACTIVITY: Dimethylallyl diphosphate + 2 oxidized
CC       ferredoxin [iron-sulfur] cluster + H(2)O = (E)-4-hydroxy-3-
CC       methylbut-2-en-1-yl diphosphate + 2 reduced ferredoxin [iron-
CC       sulfur] cluster + 2 H(+). {ECO:0000269|PubMed:12198182,
CC       ECO:0000269|PubMed:12571359}.
CC   -!- COFACTOR:
CC       Name=[3Fe-4S] cluster; Xref=ChEBI:CHEBI:21137;
CC         Evidence={ECO:0000269|PubMed:19569147,
CC         ECO:0000269|PubMed:20080550, ECO:0000269|PubMed:22137895};
CC       Note=Binds 1 [3Fe-4S] cluster per subunit.
CC       {ECO:0000269|PubMed:19569147, ECO:0000269|PubMed:20080550,
CC       ECO:0000269|PubMed:22137895};
CC   -!- ENZYME REGULATION: Addition of Ca(2+), Mg(2+), Mn(2+), Ni(2+),
CC       Co(2+) or Fe(2+) decreases the activity. Addition of Zn(2+)
CC       results in complete loss of activity.
CC       {ECO:0000269|PubMed:15469281}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=30 uM for 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate
CC         {ECO:0000269|PubMed:15469281};
CC       pH dependence:
CC         Optimum pH is 7.0.;
CC   -!- PATHWAY: Isoprenoid biosynthesis; dimethylallyl diphosphate
CC       biosynthesis; dimethylallyl diphosphate from (2E)-4-hydroxy-3-
CC       methylbutenyl diphosphate: step 1/1.
CC   -!- PATHWAY: Isoprenoid biosynthesis; isopentenyl diphosphate
CC       biosynthesis via DXP pathway; isopentenyl diphosphate from 1-
CC       deoxy-D-xylulose 5-phosphate: step 6/6.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:12706830,
CC       ECO:0000269|PubMed:19569147, ECO:0000269|PubMed:20080550,
CC       ECO:0000269|PubMed:22137895}.
CC   -!- MISCELLANEOUS: PubMed:12706830 and PubMed:22137895 authors have
CC       reported the presence of a 4Fe-4S iron-sulfur cluster. It could be
CC       due to experimental conditions.
CC   -!- SIMILARITY: Belongs to the IspH family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY062212; AAL38655.1; -; Genomic_DNA.
DR   EMBL; X54945; CAA38707.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC73140.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAB96598.1; -; Genomic_DNA.
DR   PIR; JE0403; JE0403.
DR   RefSeq; NP_414570.1; NC_000913.3.
DR   RefSeq; WP_001166395.1; NZ_LN832404.1.
DR   PDB; 3F7T; X-ray; 1.80 A; A/B=1-316.
DR   PDB; 3KE8; X-ray; 1.70 A; A/B=1-316.
DR   PDB; 3KE9; X-ray; 1.90 A; A/B=1-316.
DR   PDB; 3KEF; X-ray; 1.70 A; A/B=1-316.
DR   PDB; 3KEL; X-ray; 1.80 A; A/B=1-316.
DR   PDB; 3KEM; X-ray; 2.00 A; A/B=1-316.
DR   PDB; 3SZL; X-ray; 1.60 A; A/B=1-316.
DR   PDB; 3SZO; X-ray; 1.60 A; A/B=1-316.
DR   PDB; 3SZU; X-ray; 1.40 A; A/B=1-316.
DR   PDB; 3T0F; X-ray; 1.90 A; A/B=1-316.
DR   PDB; 3T0G; X-ray; 2.10 A; A/B=1-316.
DR   PDB; 3URK; X-ray; 1.50 A; A/B=1-316.
DR   PDB; 3UTC; X-ray; 1.90 A; A/B=1-316.
DR   PDB; 3UTD; X-ray; 1.70 A; A/B=1-316.
DR   PDB; 3UV3; X-ray; 1.60 A; A/B=1-316.
DR   PDB; 3UV6; X-ray; 1.70 A; A/B=1-316.
DR   PDB; 3UV7; X-ray; 1.60 A; A/B=1-316.
DR   PDB; 3UWM; X-ray; 1.80 A; A/B=1-316.
DR   PDB; 3ZGL; X-ray; 1.68 A; A/B=1-316.
DR   PDB; 3ZGN; X-ray; 1.95 A; A/B=1-316.
DR   PDB; 4EB3; X-ray; 1.90 A; A/B=1-315.
DR   PDB; 4H4C; X-ray; 1.80 A; A/B=1-315.
DR   PDB; 4H4D; X-ray; 1.35 A; A/B=1-315.
DR   PDB; 4H4E; X-ray; 1.70 A; A/B=1-315.
DR   PDBsum; 3F7T; -.
DR   PDBsum; 3KE8; -.
DR   PDBsum; 3KE9; -.
DR   PDBsum; 3KEF; -.
DR   PDBsum; 3KEL; -.
DR   PDBsum; 3KEM; -.
DR   PDBsum; 3SZL; -.
DR   PDBsum; 3SZO; -.
DR   PDBsum; 3SZU; -.
DR   PDBsum; 3T0F; -.
DR   PDBsum; 3T0G; -.
DR   PDBsum; 3URK; -.
DR   PDBsum; 3UTC; -.
DR   PDBsum; 3UTD; -.
DR   PDBsum; 3UV3; -.
DR   PDBsum; 3UV6; -.
DR   PDBsum; 3UV7; -.
DR   PDBsum; 3UWM; -.
DR   PDBsum; 3ZGL; -.
DR   PDBsum; 3ZGN; -.
DR   PDBsum; 4EB3; -.
DR   PDBsum; 4H4C; -.
DR   PDBsum; 4H4D; -.
DR   PDBsum; 4H4E; -.
DR   ProteinModelPortal; P62623; -.
DR   SMR; P62623; -.
DR   BioGrid; 4262917; 321.
DR   DIP; DIP-35808N; -.
DR   IntAct; P62623; 7.
DR   STRING; 511145.b0029; -.
DR   DrugBank; DB01785; Dimethylallyl Diphosphate.
DR   DrugBank; DB04714; ISOPENTENYL PYROPHOSPHATE.
DR   EPD; P62623; -.
DR   PaxDb; P62623; -.
DR   PRIDE; P62623; -.
DR   EnsemblBacteria; AAC73140; AAC73140; b0029.
DR   EnsemblBacteria; BAB96598; BAB96598; BAB96598.
DR   GeneID; 944777; -.
DR   KEGG; ecj:JW0027; -.
DR   KEGG; eco:b0029; -.
DR   PATRIC; 32115149; VBIEscCol129921_0026.
DR   EchoBASE; EB1073; -.
DR   EcoGene; EG11081; ispH.
DR   eggNOG; ENOG4105C48; Bacteria.
DR   eggNOG; COG0761; LUCA.
DR   HOGENOM; HOG000220192; -.
DR   InParanoid; P62623; -.
DR   KO; K03527; -.
DR   OMA; DDLTFMT; -.
DR   PhylomeDB; P62623; -.
DR   BioCyc; EcoCyc:EG11081-MONOMER; -.
DR   BioCyc; MetaCyc:EG11081-MONOMER; -.
DR   UniPathway; UPA00056; UER00097.
DR   UniPathway; UPA00059; UER00105.
DR   EvolutionaryTrace; P62623; -.
DR   PRO; PR:P62623; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0051538; F:3 iron, 4 sulfur cluster binding; IDA:EcoCyc.
DR   GO; GO:0051745; F:4-hydroxy-3-methylbut-2-en-1-yl diphosphate reductase activity; IEA:InterPro.
DR   GO; GO:0042380; F:hydroxymethylbutenyl pyrophosphate reductase activity; IDA:EcoCyc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050992; P:dimethylallyl diphosphate biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019288; P:isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway; IMP:EcoCyc.
DR   CDD; cd13944; lytB_ispH; 1.
DR   HAMAP; MF_00191; IspH; 1.
DR   InterPro; IPR003451; LytB/IspH.
DR   PANTHER; PTHR30426; PTHR30426; 1.
DR   Pfam; PF02401; LYTB; 1.
DR   TIGRFAMs; TIGR00216; ispH_lytB; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 3Fe-4S; Complete proteome; Iron; Iron-sulfur;
KW   Isoprene biosynthesis; Metal-binding; NADP; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN         1    316       4-hydroxy-3-methylbut-2-enyl diphosphate
FT                                reductase.
FT                                /FTId=PRO_0000128812.
FT   REGION      225    227       Substrate binding.
FT   METAL        12     12       Iron-sulfur (3Fe-4S).
FT                                {ECO:0000269|PubMed:19569147,
FT                                ECO:0000269|PubMed:20080550}.
FT   METAL        96     96       Iron-sulfur (3Fe-4S).
FT                                {ECO:0000269|PubMed:19569147,
FT                                ECO:0000269|PubMed:20080550}.
FT   METAL       197    197       Iron-sulfur (3Fe-4S).
FT                                {ECO:0000269|PubMed:19569147,
FT                                ECO:0000269|PubMed:20080550}.
FT   BINDING      41     41       Substrate. {ECO:0000269|PubMed:20080550,
FT                                ECO:0000269|PubMed:22137895}.
FT   BINDING      74     74       Substrate. {ECO:0000269|PubMed:20080550,
FT                                ECO:0000269|PubMed:22137895}.
FT   BINDING     124    124       Substrate. {ECO:0000269|PubMed:20080550,
FT                                ECO:0000269|PubMed:22137895}.
FT   BINDING     167    167       Substrate. {ECO:0000269|PubMed:20080550,
FT                                ECO:0000269|PubMed:22137895}.
FT   BINDING     269    269       Substrate. {ECO:0000269|PubMed:20080550,
FT                                ECO:0000269|PubMed:22137895}.
FT   MUTAGEN      12     12       C->S: Loss of activity.
FT                                {ECO:0000269|PubMed:15469281,
FT                                ECO:0000269|PubMed:20080550}.
FT   MUTAGEN      41     41       H->N: No effect on the activity.
FT                                {ECO:0000269|PubMed:19569147}.
FT   MUTAGEN      74     74       H->N: Reduces activity 2-fold.
FT                                {ECO:0000269|PubMed:19569147}.
FT   MUTAGEN      96     96       C->S: Loss of activity.
FT                                {ECO:0000269|PubMed:15469281,
FT                                ECO:0000269|PubMed:20080550}.
FT   MUTAGEN      99     99       V->A: No effect on the activity.
FT                                {ECO:0000269|PubMed:19569147}.
FT   MUTAGEN     124    124       H->N: Reduces activity 100-fold.
FT                                {ECO:0000269|PubMed:19569147}.
FT   MUTAGEN     126    126       E->D,Q: Reduces activity 100-fold.
FT                                {ECO:0000269|PubMed:19569147,
FT                                ECO:0000269|PubMed:22137895}.
FT   MUTAGEN     167    167       T->C: Reduces activity 3-fold.
FT                                {ECO:0000269|PubMed:19569147,
FT                                ECO:0000269|PubMed:22137895}.
FT   MUTAGEN     167    167       T->S: No effect on the activity.
FT                                {ECO:0000269|PubMed:19569147,
FT                                ECO:0000269|PubMed:22137895}.
FT   MUTAGEN     197    197       C->S: Loss of activity.
FT                                {ECO:0000269|PubMed:15469281,
FT                                ECO:0000269|PubMed:20080550}.
FT   MUTAGEN     225    225       S->C: Reduces activity 100-fold.
FT                                {ECO:0000269|PubMed:19569147}.
FT   MUTAGEN     227    227       N->Q: Reduces activity 20-fold.
FT                                {ECO:0000269|PubMed:19569147}.
FT   STRAND        2      5       {ECO:0000244|PDB:4H4D}.
FT   HELIX        13     29       {ECO:0000244|PDB:4H4D}.
FT   STRAND       33     37       {ECO:0000244|PDB:4H4D}.
FT   STRAND       39     41       {ECO:0000244|PDB:4H4D}.
FT   HELIX        43     51       {ECO:0000244|PDB:4H4D}.
FT   STRAND       54     59       {ECO:0000244|PDB:4H4D}.
FT   HELIX        60     62       {ECO:0000244|PDB:4H4D}.
FT   STRAND       68     71       {ECO:0000244|PDB:4H4D}.
FT   HELIX        78     86       {ECO:0000244|PDB:4H4D}.
FT   STRAND       90     93       {ECO:0000244|PDB:4H4D}.
FT   HELIX        97    112       {ECO:0000244|PDB:4H4D}.
FT   STRAND      115    120       {ECO:0000244|PDB:4H4D}.
FT   HELIX       125    131       {ECO:0000244|PDB:4H4D}.
FT   STRAND      137    139       {ECO:0000244|PDB:3T0G}.
FT   STRAND      141    144       {ECO:0000244|PDB:4H4D}.
FT   HELIX       147    152       {ECO:0000244|PDB:4H4D}.
FT   STRAND      160    165       {ECO:0000244|PDB:4H4D}.
FT   STRAND      167    169       {ECO:0000244|PDB:3T0F}.
FT   HELIX       171    184       {ECO:0000244|PDB:4H4D}.
FT   STRAND      191    193       {ECO:0000244|PDB:3KEM}.
FT   HELIX       198    213       {ECO:0000244|PDB:4H4D}.
FT   STRAND      215    220       {ECO:0000244|PDB:4H4D}.
FT   HELIX       226    237       {ECO:0000244|PDB:4H4D}.
FT   STRAND      241    247       {ECO:0000244|PDB:4H4D}.
FT   HELIX       248    250       {ECO:0000244|PDB:4H4D}.
FT   HELIX       253    255       {ECO:0000244|PDB:4H4D}.
FT   TURN        256    258       {ECO:0000244|PDB:4H4D}.
FT   STRAND      260    266       {ECO:0000244|PDB:4H4D}.
FT   HELIX       272    284       {ECO:0000244|PDB:4H4D}.
FT   STRAND      289    292       {ECO:0000244|PDB:4H4D}.
FT   STRAND      300    302       {ECO:0000244|PDB:4H4D}.
FT   HELIX       306    308       {ECO:0000244|PDB:4H4D}.
SQ   SEQUENCE   316 AA;  34775 MW;  0E7B378BD49AB771 CRC64;
     MQILLANPRG FCAGVDRAIS IVENALAIYG APIYVRHEVV HNRYVVDSLR ERGAIFIEQI
     SEVPDGAILI FSAHGVSQAV RNEAKSRDLT VFDATCPLVT KVHMEVARAS RRGEESILIG
     HAGHPEVEGT MGQYSNPEGG MYLVESPDDV WKLTVKNEEK LSFMTQTTLS VDDTSDVIDA
     LRKRFPKIVG PRKDDICYAT TNRQEAVRAL AEQAEVVLVV GSKNSSNSNR LAELAQRMGK
     RAFLIDDAKD IQEEWVKEVK CVGVTAGASA PDILVQNVVA RLQQLGGGEA IPLEGREENI
     VFEVPKELRV DIREVD
//
